Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kimberly Rosenthal"'
Autor:
Linda Papa, Kimberly Rosenthal, Laura Cook, Michael Caire, Josef G. Thundiyil, Jay G. Ladde, Alec Garfinkel, Carolina F. Braga, Ciara N. Tan, Neema J. Ameli, Marco A. Lopez, Crystal A. Haeussler, Diego Mendez Giordano, Philip A. Giordano, Jose Ramirez, Manoj K. Mittal, Mark R. Zonfrillo
Publikováno v:
Brain Injury. 36:939-947
This prospective multicenter study evaluated differences in concussion severity and functional outcome using glial and neuronal biomarkers glial Fibrillary Acidic (GFAP) and Ubiquitin C-terminal Hydrolase (UCH-L1) in children and youth involved in no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a0e340f0c2ea0096dd58d205f490b7a
https://doi.org/10.1080/02699052.2022.2106383
https://doi.org/10.1080/02699052.2022.2106383
Autor:
Stephen B. Lewis, Linda Papa, Kimberly Rosenthal, John C. Axley, Jared M. Kelly, Francesca Silvestri
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
Scientific Reports
Scientific Reports
This study assessed whether cytoskeletal protein alpha-II spectrin breakdown products (SBDP150, SBDP145, and SBDP120) would identify the presence of aSAH and be associated with severity (GCS score, WFNS grade and survival to hospital discharge). This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a730178ba4908f9215258eef8c1ac1de
http://link.springer.com/article/10.1038/s41598-018-31631-y
http://link.springer.com/article/10.1038/s41598-018-31631-y
Autor:
Erika Farmer, Kamelia Zerrouki, Inna Vainshtein, Meina Liang, Jeffrey M. Riggs, Bhargavi Rajan, Chris Morehouse, Kevin Schifferli, Kimberly Rosenthal, Richard N. Hanna, Divya Sagar, Melissa de los Reyes, Roland Kolbeck, Miguel A. Sanjuan, Gary P. Sims, Jodi L. Karnell
Publikováno v:
Lupus Science & Medicine
Objective We investigated the mechanistic and pharmacological properties of anifrolumab, a fully human, effector-null, anti-type I interferon (IFN) alpha receptor 1 (IFNAR1) monoclonal antibody in development for SLE. Methods IFNAR1 surface expressio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22fa428a324c906d6d44a467974ace77
https://doi.org/10.1136/lupus-2018-000261
https://doi.org/10.1136/lupus-2018-000261